US Patent 9708324 Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+151 characters)
Article
Patent abstract
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Andreas Goutopoulos0
Catherine Jorand-Lebrun0
Henry Yu0
Ruoxi Lan0
Theresa L. Johnson0
Xiaoling Chen0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09708324 Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof US Patent 9708324 Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
Infobox
Patent Number
097083240
Patent Number
97083240
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
097083240
Date of Patent
July 18, 2017
0Patent Application Number
150165690
Date Filed
February 5, 2016
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 13 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09708324 Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
Infobox
Is a
Patent jurisdiction
Patent number
09708324
Date of patent
July 18, 2017
Patent application number
15016569
Date Filed
February 5, 2016
Patent primary examiner
Find more entities like US Patent 9708324 Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
